The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases
Clinical Genetics · 2024-10 · 106 (4) · 394-402
DOI: 10.1111/cge.14569 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Genetics, online erschienen am 04.06.2024. Verfasst von Catia Mio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (DMED), University of Udine, Udine, Italy. Hauptthemen laut MEDLINE: Genetic Testing, Exome Sequencing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In the last decade, an incredible improvement has been made in elucidating the genetic bases of cardiomyopathies. Here we report the impact of either the European Society of Cardiology (ESC) guidelines or the use of whole exome sequencing (WES) in terms of a number of variants of uncertain significance (VUS) and missed diagnoses in a series of 260 patients affected by inherited cardiac disorders. Samples were analyzed using a targeted gene panel of 128 cardiac‐related genes and/or WES in a subset of patients, with a three‐tier approach. Analyzing (i) only a subset of genes related to the clinical presentation, strictly following the ESC guidelines, 20.77% positive test were assessed. The incremental diagnostic rate for (ii) the whole gene panel, and (iii) the WES was 4.71% and 11.67%, respectively. The diverse analytical approaches increased the number of VUSs and incidental findings. Indeed, the use of WES highlights that there is a small percentage of syndromic conditions that standard analysis would not have detected. Moreover, the use of targeted sequencing coupled with “narrow” analytical approach prevents the detection of variants in actionable genes that could allow for preventive treatment. Our data suggest that genetic testing might aid clinicians in the diagnosis of inheritable cardiac disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine (DMED), University of Udine, Udine, Italy.
- Institute of Medical Genetics, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy.
- Cardiology, Cardiothoracic Department, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy.
ORCID-Profile: Catia Mio, Federica Baldan, Flavio Faletra
Zitieren
APA
Mio, C., Zucco, J., Fabbro, D., Bregant, E., Baldan, F., Allegri, L., D'Elia, A. V., Collini, V., Imazio, M., Damante, G., & Faletra, F. (2024). The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases. Clinical Genetics, 106(4), 394-402. https://doi.org/10.1111/cge.14569
Vancouver
Mio C, Zucco J, Fabbro D, Bregant E, Baldan F, Allegri L, et al. The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases. Clinical Genetics. 2024;106(4):394-402. doi:10.1111/cge.14569
BibTeX
@article{Mio2024,
author = {Mio, Catia and Zucco, Jessica and Fabbro, Dora and Bregant, Elisa and Baldan, Federica and Allegri, Lorenzo and D'Elia, Angela Valentina and Collini, Valentino and Imazio, Massimo and Damante, Giuseppe and Faletra, Flavio},
title = {The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases},
journal = {Clinical Genetics},
year = {2024},
volume = {106},
number = {4},
pages = {394--402},
doi = {10.1111/cge.14569}
}
EUVIMED